Sarah JS Glickman's Net Worth

$17.8 Million

Estimate Recalculated Nov 11, 2024 07:52AM EST

Who is Sarah JS Glickman

Sarah JS Glickman has an estimated net worth of $17.8 Million. This is based on reported shares across multiple companies, which include 2seventy bio, Inc., Criteo S.A., XPO Logistics, Inc., bluebird bio, Inc., and APTARGROUP, INC..

SEC CIK

Sarah JS Glickman's CIK is 0001749338

Past Insider Trading and Trends

2021 was Sarah JS Glickman's most active year for acquiring shares with 5 total transactions. Sarah JS Glickman's most active month to acquire stocks was the month of May. 2023 was Sarah JS Glickman's most active year for disposing of shares, totalling 8 transactions. Sarah JS Glickman's most active month to dispose stocks was the month of September. 2022 saw Sarah JS Glickman paying a total of $0.00 for 165,735 shares, this is the most they've acquired in one year. In 2022 Sarah JS Glickman cashed out on 53,734 shares for a total of $1,399,582.64, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

2seventy bio, Inc.

Investor
Updated Jun 12, 2024
Form 4
231.70%
36.15K
Jun 12, 2024
51.75K
Grant
Jun 10
Form 4
351.29%
25.30K
Jun 15, 2023
32.50K
Grant
Jun 13
Form 4
619.59%
18.60K
Jun 09, 2022
21.60K
Grant
Jun 08
Form 4
7.83K
Nov 16, 2021
7.83K
Grant
Nov 11
Form 3
Oct 18, 2021
Showing 5 results

Criteo S.A.

Chief Financial Officer
Updated Oct 25, 2024
Form 4
-1.71%
-5.44K
$40.60
-$220.95K
Oct 25, 2024
313.40K
Sale
Oct 23
Form 4
-0.47%
-1.52K
$49.17
-$74.69K
Aug 27, 2024
318.68K
Sale
Aug 26
Form 4
-1.69%
-5.50K
$45.49
-$250.01K
Jul 25, 2024
320.20K
Sale
Jul 23
Form 4
-0.47%
-1.53K
$38.99
-$59.85K
May 24, 2024
325.70K
Sale
May 24
Form 4
-1.65%
-5.50K
$35.40
-$194.84K
Apr 23, 2024
327.23K
Sale
Apr 23
Form 4
13.55%
39.72K
Mar 01, 2024
332.74K
Grant
Mar 01
Form 4
17.35%
43.31K
$32.69
-$315.56K
Feb 26, 2024
293.02K
Grant
Feb 23 - Feb 26
Form 4
-1.43%
-3.62K
$24.74
-$89.61K
Jan 24, 2024
249.71K
Sale
Jan 23
Form 4
-2.13%
-5.50K
$28.16
-$154.98K
Oct 25, 2023
253.33K
Sale
Oct 23
Form 4
-2.07%
-5.46K
$32.63
-$178.18K
Jul 26, 2023
258.83K
Sale
Jul 24
Form 4
-1.87%
-5.04K
$30.27
-$152.62K
Apr 26, 2023
264.29K
Sale
Apr 24
Form 4
35.98%
71.26K
Feb 27, 2023
269.34K
Grant
Feb 23
Form 4
-2.78%
-5.65K
$28.95
-$163.67K
Jan 24, 2023
198.07K
Sale
Jan 23
Form 4
-20.87%
-53.73K
$26.05
-$1.40M
Oct 25, 2022
203.73K
Sale
Oct 24
Form 4
133.36%
147.13K
Feb 28, 2022
257.46K
Grant
Feb 24
Form 4
110.33K
Oct 27, 2020
110.33K
Grant
Oct 23
Form 3
Sep 16, 2020
Showing 17 results

XPO Logistics, Inc.

Acting Chief Financial Officer
Updated Jun 11, 2019
Form 4
-5.23%
-891.00
$53.78
-$47.92K
Jun 11, 2019
16.16K
Options
Jun 10
Form 4
1.90K
Apr 22, 2019
1.90K
Grant
Apr 18
Form 3
Aug 16, 2018
Showing 3 results

bluebird bio, Inc.

Investor
Updated Nov 17, 2021
Form 4
-100.00%
-7.50K
Nov 17, 2021
Disposition
Nov 11
Form 3
Oct 01, 2021
Form 4
12.16K
Oct 01, 2021
12.16K
Grant
Sep 29
Showing 3 results

APTARGROUP, INC.

Investor
Updated May 02, 2024
Form 4
124.50%
1.11K
May 02, 2024
2.01K
Grant
May 01
Form 4
894.00
Oct 18, 2023
894.00
Grant
Oct 17
Form 3
Oct 16, 2023
Showing 3 results